Renal Cell Carcinoma

RENAL CELL CARCINOMA ADVISOR

HEADLINES
TREATMENT REGIMENS
DRUG INFORMATION

FEATURED CONTENT

Can Quality of Life Assessments Predict PFS, OS Across Cancer Types?

Recent studies showed associations between quality of life scores and survival in lung and prostate cancer as well as renal cell carcinoma.
PTSD in Cancer Patients: What Providers Need to Know

Experts outline risk factors for PTSD and explain how PTSD can affect cancer outcomes.
Changes in Clinical Trial Conduct Prompted by the COVID-19 Pandemic Should Persist

The AACR COVID-19 and Cancer Task Force recommends keeping changes to clinical trial practices that were prompted by the pandemic.
ASCO and Friends: Cancer Patients Should Be Included in COVID-19 Vaccine Trials

A statement recommends including cancer patients and survivors in COVID-19 vaccine trials.
Closing the Gap Between Cancer Patients and Researchers: A Patient Advocate’s Perspective on GRASP

Patient advocate Marlena Murphy provides a patient’s perspective on GRASP.

RENAL CELL CARCINOMA NEWS

Diabetes Not a Major Driver of Oncologic Outcomes in Renal Cell Carcinoma

December 7, 2021

Male patient in exam room talking to doctor.

Belzutifan Demonstrates Efficacy in VHL-Associated Renal Cell Carcinoma

December 3, 2021

Man undergoing radiation treatment

Radiation Therapy for Oligometastatic Renal Cell Carcinoma Promising

November 16, 2021

Adverse Radiologic and Pathologic Features Predict Worse Survival Outcomes in Small Renal Masses Following Nephrectomy

November 11, 2021

Doctor performing surgery.

Cytoreductive Nephrectomy Plus Active Surveillance Benefits Some With Metastatic Renal Cell Carcinoma

November 10, 2021

Next post in Renal Cell Carcinoma

Male patient in exam room talking to doctor.

Belzutifan Demonstrates Efficacy in VHL-Associated Renal Cell Carcinoma